Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen
New effective tools for vaccine strategies are necessary to limit the spread of bluetongue, an insect-transmitted viral disease of domestic and wild ruminants. In the present study, BoHV-4-based vector cloned as a bacterial artificial chromosome (BAC) was engineered to express the bluetongue virus (BTV) immune-dominant glycoprotein VP2 provided of a heterologous signal peptide to its amino terminal and a trans-membrane domain to its carboxyl terminal (IgK-VP2gDtm), to allow the VP2 expression targeting to the cell membrane fraction. Based on adult α/β interferon receptor knockout (IFNAR(-/-)) mice, a newly generated bluetongue laboratory animal model, a pre-challenge experiment was performed to test BoHV-4 safety on such immune-compromised animal. BoHV-4 infected IFNAR(-/-) mice did not show clinical signs even following the inoculation of BoHV-4 intra-cerebrally, although many areas of the brain got transduced. IFNAR(-/-) mice intraperitoneally inoculated twice with BoHV-4-A-IgK-VP2gDtm at different time points developed serum neutralizing antibodies against BTV and showed a strongly reduced viremia and a longer survival time when challenged with a lethal dose of BTV-8. The data acquired in this pilot study validate BoHV-4-based vector as a safe and effective heterologous antigen carrier/producer for the formulation of enhanced recombinant immunogens for the vaccination against lethal bluetongue. © 2011 Elsevier Ltd.
Main Authors: | Franceschi, V., Capocefalo, A., Calvo Pinilla, Eva María, Redaelli, M., Mucignat-Caretta, C., Mertens, P., Ortego Alonso, Francisco Javier, Donofrio, G. |
---|---|
Format: | journal article biblioteca |
Language: | English |
Published: |
Elsevier
2011
|
Subjects: | Viral vector, Bovine herpesvirus 4, BTV, VP2, |
Online Access: | http://hdl.handle.net/20.500.12792/1488 http://hdl.handle.net/10261/293247 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant Modified Vaccinia Virus Ankara Development to Express VP2, NS1, and VP7 Proteins of Bluetongue Virus
by: Marín-López, Alejandro, et al.
Published: (2022-02-03) -
Viral Vector Vaccines against Bluetongue Virus
by: Jiménez-Cabello, L., et al.
Published: (2020-12-25) -
Eficacia de un herpesvirus de pavo recombinante expresando la proteína VP2 del virus de la enfermedad de Gumboro ante un desafío experimental
by: Perozo, F., et al. -
Inhibition of the IFN Response by Bluetongue Virus: The Story So Far
by: Rojas, José Manuel, et al.
Published: (2021-06-08) -
Isolation and expression of recombinant viral protein (VP2) from Iranian isolates of Infectious Pancreatic Necrosis Virus (IPNV) in Escherichia coli
by: Dadar, M., et al.
Published: (2014)